Clinical Trials Directory

Trials / Completed

CompletedNCT03736304

The Effect of Automated Electronic Alert for Acute Kidney Injury on the Outcomes of Hospitalized Patients

The Effect of Automated Electronic Alert for Acute Kidney Injury on the Outcomes of Hospitalized Patients: a Single Center Randomized Controlled Trial.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
4,536 (actual)
Sponsor
The First Affiliated Hospital with Nanjing Medical University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Acute kidney injury (AKI) is a common disease, but diagnosis is usually delayed or missed in hospitalized patients. The automated electronic alert for AKI may help to improve the outcomes of these patients through identifying all cases of AKI early. Therefore, the investigators conduct a randomly controlled study to test whether automated electronic alert for AKI could improve the outcomes of hospitalized patients.

Detailed description

Acute kidney injury (AKI) is a common disease, but diagnosis is usually delayed or missed in hospitalized patients. The automated electronic alert for AKI may help to improve the outcomes of these patients through identifying all cases of AKI early. Therefore, the investigators conduct a randomly controlled study to test whether automated electronic alert for AKI could improve the outcomes of hospitalized patients. The patients were randomly divided into two groups: Usual care : patients will receive standard clinical care by the primary physicians AKI alert : an AKI alert will be sent to the doctor in charge. The team of kidney experts would give a suggestion if the doctor in charge need a renal consultation.

Conditions

Interventions

TypeNameDescription
DEVICEAKI alertAn AKI alert will send to the doctor in charge. The team of nephrologists would give suggestions if the doctor in charge need a renal consultation.
OTHERUsual carePatients will receive standard clinical care by the doctor in charge.

Timeline

Start date
2019-08-01
Primary completion
2022-01-31
Completion
2022-01-31
First posted
2018-11-09
Last updated
2024-01-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03736304. Inclusion in this directory is not an endorsement.